Immediate Impact
60 standout
Citing Papers
Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial
2022 Standout
Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I
2021 Standout
Works of Joan Basiuk being referenced
Management of advanced kidney cancer: Canadian Kidney Cancer Forum consensus update
2015
Growth kinetics of small renal masses: A prospective analysis from the Renal Cell Carcinoma Consortium of Canada
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Joan Basiuk | 167 | 64 | 38 | 11 | 226 | |
| J. Fox | 81 | 46 | 91 | 8 | 265 | |
| Chris Saigal | 153 | 81 | 25 | 13 | 246 | |
| Joanna Harton | 113 | 30 | 64 | 18 | 259 | |
| N. Coakley | 147 | 43 | 111 | 11 | 275 | |
| Carolyn Aldigé | 58 | 42 | 58 | 8 | 225 | |
| Jill Feldman | 158 | 18 | 58 | 19 | 270 | |
| Joshua J. McFarlane | 95 | 43 | 106 | 8 | 235 | |
| Alfred Oliver | 77 | 55 | 102 | 10 | 282 | |
| Polyxeni Dimitropoulou | 92 | 40 | 35 | 12 | 274 | |
| J. Mackay | 143 | 21 | 149 | 11 | 299 |
All Works
Loading papers...